SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 22 - Sayı: 3

Turkish Society of Cardiology consensus report on recommendations for athletes with high-risk genetic cardiovascular diseases or implanted cardiac devices

Erdem ÖZEL
Mustafa Feridun KOŞAR
Emin Evren ÖZCAN
Burak HÜNÜK
Pages
140–150
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, intense physical activity, especially in a competitive fashion, may become hazardous to genetically vulnerable individuals

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Regular exercise has many favorable effects on the cardiovascular system.
📊
Key Findings & Data:Regular exercise has many favorable effects on the cardiovascular system.
💡
Conclusion & Impact:However, intense physical activity, especially in a competitive fashion, may become hazardous to genetically vulnerable individuals
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Regular exercise has many favorable effects on the cardiovascular system. However, intense physical activity, especially in a competitive fashion, may become hazardous to genetically vulnerable individuals

🔖

Cite This Article

ÖZEL, E., KOŞAR, M. F., ÖZCAN, E. E., HÜNÜK, B. (2019). Turkish Society of Cardiology consensus report on recommendations for athletes with high-risk genetic cardiovascular diseases or implanted cardiac devices. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 3, 140–150. https://ajindex.com/articles/365754

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol 2005; 45: 1318–21
  2. Harmon KG, Asif IM, Klossner D, Drezner JA. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation 2011; 123: 1594-600
  3. Malhotra A, Dhutia H, Finocchiaro G, Gati S, Beasley I, Clift P, et al. Outcomes of Cardiac Screening in Adolescent Soccer Players. N Engl J Med 2018; 379: 524-34
  4. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009; 119: 1085-92
  5. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003; 42: 1959-63
  6. Finocchiaro G, Papadakis M, Robertus JL, Dhutia H, Steriotis AK, Tome M, et al. Etiology of Sudden Death in Sports: Insights From a United Kingdom Regional Registry. J Am Coll Cardiol 2016; 67: 2108-15
  7. Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-79
  8. Peterson DF, Siebert DM, Kucera KL, Thomas LC, Maleszewski JJ, Lopez-Anderson M, et al. Etiology of Sudden Cardiac Arrest and Death in US Competitive Athletes: A 2-Year Prospective Surveillance Study. Clin J Sport Med 2018; doi: 10.1097/JSM.0000000000000598. [Epub ahead of print] 9. Sheikh N, Papadakis M, Schnell F, Panoulas V, Malhotra A, Wilson M, et al. Clinical Profile of Athletes With Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging 2015; 8: e003454
  9. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, et al.; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathie